Breaking News

Selexis Promotes Dr. Yemi Onakunle to Chief Business Officer

Industry expert with 20+ years’ experience in biopharmaceutical drug development and manufacturing.

Selexis SA has promoted Yemi Onakunle to chief business officer. In this new and expanded role, Dr. Onakunle will relocate to Selexis headquarters in Geneva, Switzerland and will lead all corporate and business development activities, reporting directly to chief executive officer Igor Fisch.   “Yemi has a great knowledge base in both the cell line development and contract development and manufacturing organization (CDMO) market segments. In his previous role at Selexis, he has been able to secur...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters